FdaApplication
NDA 217729
Identifiers
- fda_app_no: NDA217729
Properties
| Property | Value |
|---|---|
| applicant_name | PF PRISM CV |
| application_type | NDA |
| approval_date | 2023-09-26 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| BOSULIF | BOSUTINIB MONOHYDRATE | EQ 100MG BASE | CAPSULE;ORAL |
| BOSULIF | BOSUTINIB MONOHYDRATE | EQ 50MG BASE | CAPSULE;ORAL |
2 products